Students in CIRM's Bridges program showing posters of their work If you have read the headlines lately, you’ll know that the COVID-19 pandemic is having a huge impact on the shipping industry. Container vessels are forced to sit out at anchor for a week or more because there just aren’t enough dock workers to unload … Continue reading Creating a diverse group of future scientists
Children’s Hospital Oakland Research Institute
Explaining COVID can be a pitch
When people ask me what I do at CIRM I sometimes half-jokingly tell them that I’m the official translator: I take complex science and turn it into everyday English. That’s important. The taxpayers of California have a right to know how their money is being spent and how it might benefit them. But that message … Continue reading Explaining COVID can be a pitch
Saying farewell to an old friend
There are some people who, when you think of them, always bring a smile to your face. Dr. Bert Lubin was one of those people. Sadly, we lost Bert to brain cancer two days ago. But the impact he had, not just as an advocate for stem cell research but as a pioneer in sickle … Continue reading Saying farewell to an old friend
Stem Cell Agency Board Approves 50th Clinical Trial
May 4th, 2011 marked a landmark moment for the California Institute for Regenerative Medicine (CIRM). On that day the Stem Cell Agency’s Board voted to invest in its first ever clinical trial, which was also the first clinical trial to use cells derived from embryonic stem cells. Today the Stem Cell Agency reached another landmark, … Continue reading Stem Cell Agency Board Approves 50th Clinical Trial
CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
The five-year survival rate for people diagnosed with the most advanced stage of non-small cell lung cancer (NSCLC) is pretty grim, only between one and 10 percent. To address this devastating condition, the Board of the California Institute for Regenerative Medicine (CIRM) today voted to invest almost $12 million in a team from UCLA that … Continue reading CIRM invests in stem cell clinical trial targeting lung cancer and promising research into osteoporosis and incontinence
Translating great stem cell ideas into effective therapies
In science, there are a lot of terms that could easily mystify people without a research background; “translational” is not one of them. Translational research simply means to take findings from basic research and advance them into something that is ready to be tested in people in a clinical trial. Yesterday our Governing Board approved … Continue reading Translating great stem cell ideas into effective therapies
Sickle Cell Disease Leaves No Organ Untouched
“There really isn’t an organ in the body that isn’t affected by sickle cell disease.” This striking comment was made by the Dr. Bertram Lubin, the CEO and President of the Children’s Hospital Oakland Research Institute (CHORI) and a CIRM Board Member. Yesterday Dr. Lubin visited CIRM headquarters to talk about sickle cell disease (SCD). … Continue reading Sickle Cell Disease Leaves No Organ Untouched
The Stem Cellar 